nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—STK10—renal vein—abdominal aortic aneurysm	0.177	0.374	CbGeAlD
Gefitinib—STK10—renal artery—abdominal aortic aneurysm	0.119	0.252	CbGeAlD
Gefitinib—STK10—blood plasma—abdominal aortic aneurysm	0.0174	0.0368	CbGeAlD
Gefitinib—SBK1—spinal cord—abdominal aortic aneurysm	0.0149	0.0315	CbGeAlD
Gefitinib—ERBB3—connective tissue—abdominal aortic aneurysm	0.012	0.0254	CbGeAlD
Gefitinib—MKNK2—connective tissue—abdominal aortic aneurysm	0.0114	0.0241	CbGeAlD
Gefitinib—ERBB3—kidney—abdominal aortic aneurysm	0.0102	0.0216	CbGeAlD
Gefitinib—CYP2C19—blood plasma—abdominal aortic aneurysm	0.00892	0.0189	CbGeAlD
Gefitinib—CSNK1E—spinal cord—abdominal aortic aneurysm	0.00824	0.0174	CbGeAlD
Gefitinib—IRAK4—spinal cord—abdominal aortic aneurysm	0.00811	0.0171	CbGeAlD
Gefitinib—ERBB3—spinal cord—abdominal aortic aneurysm	0.00795	0.0168	CbGeAlD
Gefitinib—STK10—kidney—abdominal aortic aneurysm	0.0079	0.0167	CbGeAlD
Gefitinib—MKNK2—spinal cord—abdominal aortic aneurysm	0.00756	0.016	CbGeAlD
Gefitinib—MKNK1—spinal cord—abdominal aortic aneurysm	0.00747	0.0158	CbGeAlD
Gefitinib—CYP3A5—blood plasma—abdominal aortic aneurysm	0.00703	0.0148	CbGeAlD
Gefitinib—CYP2C9—blood plasma—abdominal aortic aneurysm	0.00692	0.0146	CbGeAlD
Gefitinib—MAP2K5—spinal cord—abdominal aortic aneurysm	0.00549	0.0116	CbGeAlD
Gefitinib—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00527	0.0111	CbGeAlD
Gefitinib—CYP2D6—blood plasma—abdominal aortic aneurysm	0.00519	0.011	CbGeAlD
Gefitinib—ORM1—spinal cord—abdominal aortic aneurysm	0.00446	0.00942	CbGeAlD
Gefitinib—ABCB1—blood plasma—abdominal aortic aneurysm	0.00373	0.00789	CbGeAlD
Gefitinib—CYP1A1—kidney—abdominal aortic aneurysm	0.00326	0.00688	CbGeAlD
Gefitinib—CYP3A5—kidney—abdominal aortic aneurysm	0.00318	0.00673	CbGeAlD
Gefitinib—ABCG2—spinal cord—abdominal aortic aneurysm	0.00267	0.00565	CbGeAlD
Gefitinib—CYP3A4—kidney—abdominal aortic aneurysm	0.00239	0.00505	CbGeAlD
Gefitinib—CYP2D6—kidney—abdominal aortic aneurysm	0.00235	0.00497	CbGeAlD
Gefitinib—ABCB1—kidney—abdominal aortic aneurysm	0.00169	0.00358	CbGeAlD
Gefitinib—ABCB1—spinal cord—abdominal aortic aneurysm	0.00132	0.00278	CbGeAlD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.000837	0.00159	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—AAAS—abdominal aortic aneurysm	0.000825	0.00157	CbGpPWpGaD
Gefitinib—IRAK1—Regulation of toll-like receptor signaling pathway—NFKB1—abdominal aortic aneurysm	0.000817	0.00155	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—SELL—abdominal aortic aneurysm	0.000815	0.00155	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000809	0.00154	CbGpPWpGaD
Gefitinib—IRAK1—Toll-Like Receptors Cascades—NFKB1—abdominal aortic aneurysm	0.000808	0.00153	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.000808	0.00153	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000801	0.00152	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—MMP9—abdominal aortic aneurysm	0.000785	0.00149	CbGpPWpGaD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	0.000784	0.00149	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.000754	0.00143	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.000749	0.00142	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.000748	0.00142	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000745	0.00141	CbGpPWpGaD
Gefitinib—CYP2C19—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000738	0.0014	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—MMP2—abdominal aortic aneurysm	0.000731	0.00139	CbGpPWpGaD
Gefitinib—ERBB3—Disease—LRP1—abdominal aortic aneurysm	0.000724	0.00138	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—LDLR—abdominal aortic aneurysm	0.000721	0.00137	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.000718	0.00136	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—SERPINE1—abdominal aortic aneurysm	0.000717	0.00136	CbGpPWpGaD
Gefitinib—CYP1A1—PPARA activates gene expression—AGT—abdominal aortic aneurysm	0.000715	0.00136	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00071	0.00135	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000703	0.00133	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	0.000702	0.00133	CbGpPWpGaD
Gefitinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—abdominal aortic aneurysm	0.0007	0.00133	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—NCF1—abdominal aortic aneurysm	0.000698	0.00132	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—AAAS—abdominal aortic aneurysm	0.000681	0.00129	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—SELL—abdominal aortic aneurysm	0.000679	0.00129	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—NCF1—abdominal aortic aneurysm	0.000674	0.00128	CbGpPWpGaD
Gefitinib—CYP2C9—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.000673	0.00128	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000666	0.00126	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.000662	0.00126	CbGpPWpGaD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.000661	0.00125	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000649	0.00123	CbGpPWpGaD
Gefitinib—ALB—Platelet degranulation—SERPINE1—abdominal aortic aneurysm	0.000646	0.00123	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.000642	0.00122	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.00063	0.0012	CbGpPWpGaD
Gefitinib—ERBB3—Disease—AAAS—abdominal aortic aneurysm	0.000629	0.00119	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000623	0.00118	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.000622	0.00118	CbGpPWpGaD
Gefitinib—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—abdominal aortic aneurysm	0.000616	0.00117	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000607	0.00115	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.000599	0.00114	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.000596	0.00113	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000584	0.00111	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000572	0.00109	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.000571	0.00108	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—AAAS—abdominal aortic aneurysm	0.000567	0.00108	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—MMP9—abdominal aortic aneurysm	0.00056	0.00106	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NCF1—abdominal aortic aneurysm	0.000556	0.00106	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000554	0.00105	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000551	0.00105	CbGpPWpGaD
Gefitinib—ERBB3—Disease—LDLR—abdominal aortic aneurysm	0.000549	0.00104	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—MMP9—abdominal aortic aneurysm	0.000546	0.00104	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.000533	0.00101	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000526	0.000999	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.000523	0.000993	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NCF1—abdominal aortic aneurysm	0.000514	0.000975	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000512	0.000971	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.000511	0.000969	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000507	0.000963	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000505	0.000958	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—SELL—abdominal aortic aneurysm	0.000499	0.000946	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000492	0.000935	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000488	0.000927	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000487	0.000925	CbGpPWpGaD
Gefitinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—abdominal aortic aneurysm	0.000482	0.000915	CbGpPWpGaD
Gefitinib—MKNK1—Disease—APOE—abdominal aortic aneurysm	0.00048	0.000911	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000475	0.000901	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000472	0.000896	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—abdominal aortic aneurysm	0.000472	0.000896	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00047	0.000892	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000467	0.000886	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NCF1—abdominal aortic aneurysm	0.000463	0.000879	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000459	0.000871	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.000454	0.000862	CbGpPWpGaD
Gefitinib—EGFR—Immune System—SELL—abdominal aortic aneurysm	0.000454	0.000861	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—NFKB1—abdominal aortic aneurysm	0.000451	0.000855	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—P2RY12—abdominal aortic aneurysm	0.000449	0.000852	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000447	0.000849	CbGpPWpGaD
Gefitinib—MKNK1—Disease—NOS2—abdominal aortic aneurysm	0.000447	0.000849	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000434	0.000825	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000424	0.000805	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000422	0.000802	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—NFKB1—abdominal aortic aneurysm	0.000417	0.000791	CbGpPWpGaD
Gefitinib—EGFR—Disease—LRP1—abdominal aortic aneurysm	0.000403	0.000766	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000399	0.000757	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000395	0.00075	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000394	0.000749	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000384	0.00073	CbGpPWpGaD
Gefitinib—EGFR—Immune System—AAAS—abdominal aortic aneurysm	0.000379	0.00072	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000379	0.000719	CbGpPWpGaD
Gefitinib—MKNK1—Disease—SERPINE1—abdominal aortic aneurysm	0.000377	0.000715	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—MMP2—abdominal aortic aneurysm	0.000374	0.000709	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—APOE—abdominal aortic aneurysm	0.000373	0.000708	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000373	0.000708	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000363	0.000689	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000361	0.000685	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00036	0.000683	CbGpPWpGaD
Gefitinib—EGFR—Disease—AAAS—abdominal aortic aneurysm	0.00035	0.000665	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—NOS2—abdominal aortic aneurysm	0.000348	0.00066	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000343	0.000651	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000338	0.000641	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000336	0.000638	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000331	0.000629	CbGpPWpGaD
Gefitinib—MKNK1—Disease—PTGS2—abdominal aortic aneurysm	0.000329	0.000624	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00032	0.000608	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000316	0.0006	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000314	0.000597	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NCF1—abdominal aortic aneurysm	0.00031	0.000588	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000307	0.000583	CbGpPWpGaD
Gefitinib—EGFR—Disease—LDLR—abdominal aortic aneurysm	0.000306	0.00058	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000302	0.000573	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.0003	0.000569	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000299	0.000568	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000297	0.000564	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—SERPINE1—abdominal aortic aneurysm	0.000293	0.000556	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000289	0.000548	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000287	0.000544	CbGpPWpGaD
Gefitinib—EGFR—Disease—NCF1—abdominal aortic aneurysm	0.000286	0.000543	CbGpPWpGaD
Gefitinib—ERBB3—Disease—APOE—abdominal aortic aneurysm	0.000284	0.00054	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000282	0.000536	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000282	0.000536	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—MMP9—abdominal aortic aneurysm	0.000281	0.000533	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—AAAS—abdominal aortic aneurysm	0.000274	0.00052	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000272	0.000517	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000271	0.000514	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000267	0.000507	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000267	0.000506	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000267	0.000506	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NOS2—abdominal aortic aneurysm	0.000265	0.000503	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000264	0.000501	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000264	0.000501	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000262	0.000497	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000261	0.000496	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000257	0.000489	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PTGS2—abdominal aortic aneurysm	0.000256	0.000485	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000247	0.000468	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000243	0.00046	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00024	0.000456	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—LDLR—abdominal aortic aneurysm	0.000239	0.000454	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—NFKB1—abdominal aortic aneurysm	0.00023	0.000436	CbGpPWpGaD
Gefitinib—ERBB3—Disease—SERPINE1—abdominal aortic aneurysm	0.000223	0.000424	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00022	0.000417	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000214	0.000407	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000214	0.000406	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000214	0.000406	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000211	0.0004	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000207	0.000392	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000205	0.000389	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000203	0.000386	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000202	0.000383	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MMP9—abdominal aortic aneurysm	0.0002	0.00038	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.0002	0.00038	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.0002	0.000379	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000199	0.000378	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000198	0.000376	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—AAAS—abdominal aortic aneurysm	0.000196	0.000372	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PTGS2—abdominal aortic aneurysm	0.000195	0.00037	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000192	0.000364	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000192	0.000364	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000188	0.000357	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—AAAS—abdominal aortic aneurysm	0.000185	0.000352	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NFKB1—abdominal aortic aneurysm	0.000183	0.000348	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS2—abdominal aortic aneurysm	0.000176	0.000333	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000175	0.000332	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000175	0.000332	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000174	0.00033	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000171	0.000325	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—LDLR—abdominal aortic aneurysm	0.000171	0.000325	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000169	0.000321	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AAAS—abdominal aortic aneurysm	0.000169	0.000321	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000168	0.000319	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000167	0.000318	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000166	0.000315	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000162	0.000308	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—LDLR—abdominal aortic aneurysm	0.000162	0.000307	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000161	0.000305	CbGpPWpGaD
Gefitinib—EGFR—Disease—APOE—abdominal aortic aneurysm	0.000158	0.0003	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000158	0.000299	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000157	0.000298	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000157	0.000298	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000156	0.000297	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000155	0.000295	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000154	0.000292	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NFKB1—abdominal aortic aneurysm	0.000152	0.000289	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AAAS—abdominal aortic aneurysm	0.000152	0.000288	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000148	0.000281	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000148	0.000281	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS2—abdominal aortic aneurysm	0.000148	0.00028	CbGpPWpGaD
Gefitinib—ALB—Metabolism—LDLR—abdominal aortic aneurysm	0.000147	0.00028	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000143	0.000272	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000143	0.000272	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.00014	0.000266	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	0.000139	0.000265	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000139	0.000264	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	0.000138	0.000262	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—LDLR—abdominal aortic aneurysm	0.000132	0.000251	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00013	0.000247	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	0.000129	0.000245	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000129	0.000245	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—AGT—abdominal aortic aneurysm	0.000126	0.00024	CbGpPWpGaD
Gefitinib—EGFR—Disease—SERPINE1—abdominal aortic aneurysm	0.000124	0.000236	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000124	0.000236	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—APOE—abdominal aortic aneurysm	0.000124	0.000235	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000123	0.000233	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	0.000122	0.000231	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	0.000121	0.000229	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00012	0.000227	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000118	0.000225	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000117	0.000223	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000113	0.000215	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000111	0.00021	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—abdominal aortic aneurysm	0.000108	0.000206	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000105	0.0002	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NFKB1—abdominal aortic aneurysm	0.000102	0.000194	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	9.96e-05	0.000189	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	9.86e-05	0.000187	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	9.62e-05	0.000183	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL2—abdominal aortic aneurysm	9.32e-05	0.000177	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	9.12e-05	0.000173	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—AGT—abdominal aortic aneurysm	9.05e-05	0.000172	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOE—abdominal aortic aneurysm	8.87e-05	0.000168	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	8.7e-05	0.000165	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—AGT—abdominal aortic aneurysm	8.55e-05	0.000162	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—abdominal aortic aneurysm	8.48e-05	0.000161	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOE—abdominal aortic aneurysm	8.38e-05	0.000159	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	7.96e-05	0.000151	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AGT—abdominal aortic aneurysm	7.79e-05	0.000148	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOE—abdominal aortic aneurysm	7.64e-05	0.000145	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AGT—abdominal aortic aneurysm	7e-05	0.000133	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOE—abdominal aortic aneurysm	6.86e-05	0.00013	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	6.83e-05	0.00013	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	6.69e-05	0.000127	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.66e-05	0.000126	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.59e-05	0.000125	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	6.44e-05	0.000122	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	6.38e-05	0.000121	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	6.31e-05	0.00012	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	6.25e-05	0.000119	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—abdominal aortic aneurysm	6.08e-05	0.000115	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—abdominal aortic aneurysm	5.74e-05	0.000109	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—abdominal aortic aneurysm	5.23e-05	9.93e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—abdominal aortic aneurysm	4.7e-05	8.92e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	4.58e-05	8.7e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	4.32e-05	8.2e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	4.28e-05	8.13e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	4.21e-05	7.99e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	4.12e-05	7.82e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	2.82e-05	5.36e-05	CbGpPWpGaD
